ROCK-ALS: Protocol for a Randomized, Placebo-Controlled, Double-Blind Phase IIa Trial of Safety, Tolerability and Efficacy of the Rho Kinase (ROCK) Inhibitor Fasudil in Amyotrophic Lateral Sclerosis

Benutzer: Gast

Titel:: ROCK-ALS: Protocol for a Randomized, Placebo-Controlled, Double-Blind Phase IIa Trial of Safety, Tolerability and Efficacy of the Rho Kinase (ROCK) Inhibitor Fasudil in Amyotrophic Lateral Sclerosis
Dokumenttyp:: Zeitschriftenaufsatz
Autor(en):: Lingor, Paul; Weber, Markus; Camu, William; Friede, Tim; Hilgers, Reinhard; Leha, Andreas; Neuwirth, Christoph; Günther, René; Benatar, Michael; Kuzma-Kozakiewicz, Magdalena; Bidner, Helen; Blankenstein, Christiane; Frontini, Roberto; Ludolph, Albert; Koch, Jan C.
Zeitschriftentitel:: Frontiers in Neurology
Jahr:: 2019
Band / Volume:: 10
Volltext / DOI:: doi:10.3389/fneur.2019.00293
Verlag / Institution:: Frontiers Media SA
E-ISSN:: 1664-2295
Publikationsdatum:: 27.03.2019
BibTeX

Vorkommen: